More Globe Newswire

View Older Stories View Newer Stories

Feb 14, 2024 08:00AM Provectus Biopharmaceuticals Engages irlabs for Investor Relations Services
Feb 14, 2024 08:00AM 10 Barrel Brewing Launches Pub Ice: a Refreshing Twist on ‘Cheap Fun’
Feb 14, 2024 08:00AM Tyton Partners Promotes Catherine Shaw, Kate Sutherland, and Shlomy Kattan to Managing Director
Feb 14, 2024 08:00AM The Vita Coco Company to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
Feb 14, 2024 08:00AM ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir
Feb 14, 2024 08:00AM Transparent Energy Records 14th Consecutive Year of Organic Annual Revenue Growth, Establishes Broad Transactional Expertise in Renewable-Energy Procurement
Feb 14, 2024 08:00AM DCCA AWARDED $37 MILLION CONTRACT FROM DEFENSE INFORMATION SYSTEMS AGENCY
Feb 14, 2024 08:00AM Live Oak Ventures Participates in Financing of Anatomy Financial
Feb 14, 2024 08:00AM Lilium Announces FY and Q4 2023 Shareholder Letter and Webcast on February 27, 2024
Feb 14, 2024 08:00AM Image Protect, Inc. Announces Nine Month Total Debt Reduction of $1,945,860
Feb 14, 2024 08:00AM Erasca Announces Two Clinical Trial Collaboration and Supply Agreements for Trametinib to Evaluate Naporafenib Combination in SEACRAFT-1 and SEACRAFT-2 Trials
Feb 14, 2024 08:00AM First Refractory Gastric Cancer Patient Dosed in Phase 2 Trial with Novel Combination of MiNK’s Allogeneic INKT Cell Therapy and Agenus’ Botensilimab and Balstilimab
Feb 14, 2024 08:00AM Alkami to Announce Fourth Quarter 2023 Financial Results
Feb 14, 2024 08:00AM Lulus to Report Fourth Quarter and Full Year 2023 Results on March 6, 2024
Feb 14, 2024 08:00AM Carrick Therapeutics Announces First Patient Dosed in Phase 1b/2 Clinical Trial of Samuraciclib in Combination with Vepdegestrant in Patients with Advanced Breast Cancer
Feb 14, 2024 08:00AM BBSI Sets Fourth Quarter and Full Year 2023 Conference Call for Wednesday, February 28, 2024, at 5:00 p.m. ET
Feb 14, 2024 08:00AM GCM Grosvenor to Present at the UBS Financial Services Conference on February 28, 2024
Feb 14, 2024 08:00AM Kyivstar and Come Back Alive Raise UAH180M to Demine Ukraine, Reaching Campaign Target
Feb 14, 2024 08:00AM HEULIEZ secures contract to supply 200 e-buses to Marseille
Feb 14, 2024 07:58AM NANO Nuclear Energy to Present and Exhibit at Innovation Zero 2024, the UK’s Largest Net Zero Conference
Feb 14, 2024 07:53AM ZyVersa Therapeutics Highlights Review Article Substantiating That Inflammasome Activation Is Pathogenic in Multiple Neurological Diseases
Feb 14, 2024 07:50AM Clubhouse Media Group, Inc. Announces Miss Global Contestant, Patricia Rath, Joins HoneyDrip.com
Feb 14, 2024 07:48AM “Strategic, deliberate” approach key to Canada’s international knowledge partnerships
Feb 14, 2024 07:45AM BLINK CHARGING ANNOUNCES PRELIMINARY FULL-YEAR 2023 REVENUE IN EXCESS OF $140 MILLION, REITERATES ADJUSTED EBITDA PROFITABILITY TARGET
Feb 14, 2024 07:30AM Kornit Digital Reports Fourth Quarter and Full Year 2023 Results
Feb 14, 2024 07:30AM Ocugen to Host Clinical Showcase in New York City on Wednesday, February 21, 2024
Feb 14, 2024 07:30AM Evoke Pharma Announces Closing of $7.5 Million Public Offering
Feb 14, 2024 07:30AM CNH Industrial N.V. Reports Fourth Quarter and Full Year 2023 Results
Feb 14, 2024 07:30AM Midland Provides an Overview of Its 2024 Exploration Activities With Its Partners and Also Follow-Up on Its New Discoveries
Feb 14, 2024 07:30AM Medicenna Therapeutics Reports Third Quarter Fiscal 2024 Financial Results and Corporate Update
Feb 14, 2024 07:30AM Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2023 Earnings and Company Updates
Feb 14, 2024 07:30AM Sekur Private Data Ltd. Launches Small Business Solutions Marketing Efforts Amid Increased Attacks on SMBs in the USA During Election Year
Feb 14, 2024 07:30AM Annovis Bio Announces Last Patient Last Visit in the Phase II/III Study of Buntanetap in Alzheimer’s Disease
Feb 14, 2024 07:30AM CoreCard Corporation Reports Fourth Quarter and Full Year 2023 Results
Feb 14, 2024 07:28AM Conduent Recognized as a 2024 Leader in HR Benefits Administration by NelsonHall
Feb 14, 2024 07:25AM DSM: Net Asset Value(s)
Feb 14, 2024 07:23AM SFL - Fourth Quarter 2023 Results
Feb 14, 2024 07:22AM Danske Bank A/S, transactions by persons discharging managerial responsibilities
Feb 14, 2024 07:20AM Alliance Trust PLC - Net Asset Value
Feb 14, 2024 07:15AM Disclosure of transactions in the shares of Gabriel Holding A/S by persons discharging managerial responsibilities and closely related parties
Feb 14, 2024 07:15AM Ladybug's Growhouse Nutraceuticals Ltd Reports Rapid Growth as Sales Continue to Accelerate Across All Product Lines
Feb 14, 2024 07:15AM Ladybug's Growhouse Nutraceuticals Ltd Reports Rapid Growth as Sales Continue to Accelerate Across All Product Lines
Feb 14, 2024 07:13AM Genesis Launches Web-based Middle-Office Solution for Equities and Fixed-Income Trading
Feb 14, 2024 07:13AM Microbix Reports Record Results for Q1 Fiscal 2024
Feb 14, 2024 07:09AM Perella Weinberg to Present at the Bank of America 2024 Financial Services Conference
Feb 14, 2024 07:03AM Unicycive Therapeutics to Present Two Posters on Oxylanthanum Carbonate (OLC) at the Upcoming National Kidney Foundation Spring Clinical Meeting
Feb 14, 2024 07:00AM Tower Semiconductor Reports 2023 Fourth Quarter and Full Year Financial Results
Feb 14, 2024 07:00AM What is the Truth about Reconciliation? 2023 Year-End Review: Indigenous Watchdog
Feb 14, 2024 07:00AM Mirasol Doubles the Sobek Copper-Gold Project in Vicuña District, Chile, through Option Agreement with SQM on Adjacent Rosita Property
Feb 14, 2024 07:00AM Guardian Capital Announces February 2024 Cash Distributions for Guardian Capital ETFs
View Newer Stories View Older Stories